In conclusion, these findings showed that both RevCAR-E5B9 and RevCAR-E7B6 NK-92 cell systems work efficiently against GBM cells with respect to tumor cell killing and IFN-γ release in a RevTM-dependent manner. This evidence concerns the gene IFNG and glioblastoma.